Iovance Biotherapeutics, Inc. (IOVA)

2.20 -0.05 (-2.22%) USD  |  NASDAQ  |  Dec 12, 16:00
2.21 +0.01 (+0.45%) After-Hours: 20:00
More

Iovance Biotherapeutics Research and Development Expense (TTM): 303.64M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for IOVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Lantheus Holdings, Inc. 165.15M
Day One Biopharmaceuticals, Inc. 169.01M
Travere Therapeutics, Inc. 210.21M
Xenetic Biosciences, Inc. 2.630M
KalVista Pharmaceuticals, Inc. 55.64M